Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
670.45
Change Change %
-55.85 -7.69%

Updated:17 May, 2019, 15:59 PM IST

BSE
670.25
Change Change %
-54.55 -7.53%

Updated:17 May, 2019, 16:01 PM IST

Aurobindo Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18 MAR'17
Operational & Financial Ratios:
   Earnings Per Share (Rs) 30.94 29.13
   DPS(Rs) 2.50 2.50
   Book NAV/Share(Rs) 170.38 143.99
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 12.58 13.34
   ROE(%) 19.68 22.31
   ROCE(%) 19.02 19.75
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 18.01 23.18
   PCE(x) 15.06 19.85
   Price / Book(x) 3.27 4.69
   Yield(%) 0.45 0.37
   EV / Net Sales(x) 3.52 4.43
   EV / Core EBITDA(x) 13.13 16.96
   EV / EBIT(x) 15.08 19.15
   EV / CE(x) 2.29 3.27
   M Cap / Sales 3.18 4.12
Growth Ratio:
   Core Operating Income Growth 17.12 -80.31
   Operating Profit Growth 9.59 -4.93
   Net Profit Growth 6.21 4.92
   BVPS Growth 18.33 22.75
   Advances Growth 0.00 0.00
   EPS Growth(%) 6.21 4.80
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top